When is the best time to screen and evaluate for treatable genetic disorders?: A lifespan perspective
Open Access
- 6 March 2023
- journal article
- editorial
- Published by Wiley in American Journal of Medical Genetics Part C: Seminars in Medical Genetics
- Vol. 193 (1) , 44-55
Abstract
This paper focuses on the question of, “When is the best time to identify an individual at risk for a treatable genetic condition?” In this review, we describe a framework for considering the optimal timing for pursuing genetic and genomic screening for treatable genetic conditions incorporating a lifespan approach. Utilizing the concept of a carousel that represents the four broad time periods when critical decisions might be made around genetic diagnoses during a person's lifetime, we describe genetic testing during the prenatal period, the newborn period, childhood, and adulthood. For each of these periods, we describe the objectives of genetic testing, the current status of screening or testing, the near‐term vision for the future of genomic testing, the advantages and disadvantages of each approach, and the feasibility and ethical considerations of testing and treating. The notion of a “Genomics Passbook” is one where an early genomic screening evaluation could be performed on each individual through a public health program, with that data ultimately serving as a “living document” that could be queried and/or reanalyzed at prescribed times during the lifetime of that person, or in response to concerns about symptoms of a genetic disorder in that individual.Keywords
This publication has 44 references indexed in Scilit:
- Committee Opinion No. 691: Carrier Screening for Genetic ConditionsObstetrics & Gynecology, 2017
- Genetic identification of familial hypercholesterolemia within a single U.S. health care systemScience, 2016
- Aggregate penetrance of genomic variants for actionable disorders in European and African AmericansScience Translational Medicine, 2016
- Favorable outcomes after in utero transfusion in fetuses with alpha thalassemia major: a case series and review of the literaturePrenatal Diagnosis, 2016
- Prenatal and pre-implantation genetic diagnosisNature Reviews Genetics, 2016
- The Frequencies of Different Inborn Errors of Metabolism in Adult Metabolic Centres: Report from the SSIEM Adult Metabolic Physicians Group2015
- Actionable exomic incidental findings in 6503 participants: challenges of variant classificationGenome Research, 2015
- Clinical experience and follow-up with large scale single-nucleotide polymorphism–based noninvasive prenatal aneuploidy testingAmerican Journal of Obstetrics and Gynecology, 2014
- Actionable, Pathogenic Incidental Findings in 1,000 Participants’ ExomesThe American Journal of Human Genetics, 2013
- ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencingGenetics in Medicine, 2013